In order for a marketing authorisation to remain valid, a renewal is required five years after the granting of the marketing authorisation (irrespective of whether the marketing authorisation is suspended). This guideline considers issues associated with the processing of renewals in the centralised procedure to provide procedural guidance to marketing-authorisation holders. It has been developed by the Committee for Medicinal Products for Human Use following consultation of interested parties and European Commission services.